Document is current
Any future updates will be listed below
-
Authors
Wu, Youqian
Zhang, Ruiqi
Sun, Beibei
Chen, Gaoying
Xu, Fang
Chen, Xinyi
Zeng, Jiayuan
Shen, Dan
Shi, Fan
Pan, Sheng
Yao, Bingpeng
Tang, Haoyu
Shao, Zhehua
Wu, Qian
Shao, Jiawei
Zhang, Chao
Wang, Dongrui
Hu, Yongxian
Ying, Songmin
-
Funding
Funding for this research was provided by:
Key R&D Program of Zhejiang Province (2023C03009)
Key R&D Program of Zhejiang Province (2023C03022)
Natural Science Foundation of China (82370026)
Natural Science Foundation of China (82225001)
The Fundamental Research Funds for the Central Universities (226-2024-00175)
National Key R&D Program of China (2021YFA1102001)
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 5 February 2026
First Online: 13 February 2026
Declarations
:
: S.M.Y is an inventor of the Chinese patent ZL 2021 10172889.1 (granted, titled “Chimeric Antigen Receptor with Endogenous Protein Molecule Replacing Single Domain Antibody”) and the corresponding international patent application WO 2022/166665 A1 filed by ZJU.
